OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CQT56

CONNEQT Health Ltd

Advanced Medical Equipment & TechnologyVerified

Conneqt Health has a liquidity risk with a debt-to-equity ratio of 5.79 and a current ratio of 0.9, indicating that the company's liabilities significantly outweigh its equity and that it may struggle to meet short-term obligations. The company's free cash flow is negative at -17.9 million AUD, and its operating cash flow is also negative at -10.9 million AUD, suggesting that the company is not generating sufficient cash from operations to sustain its activities. In terms of profitability, Conneqt Health is not performing well, with a return on equity of -28.72% and a return on assets of -1.95%. These figures are significantly below the industry norms for a company in the Advanced Medical Equipment & Technology industry, indicating that the company is not effectively utilizing its assets or equity to generate returns. The company's revenue is concentrated in a single business segment, as it operates in the digital health technology space with a focus on cardiovascular health monitoring. There is no disclosed geographic diversification in the financial snapshot, suggesting that the company's revenue is primarily derived from its operations in Australia. Conneqt Health's growth trajectory is not evident from the provided data, as the company reported a net loss of 18.2 million AUD and an operating loss of 12.8 million AUD. The company's revenue for the latest period is 3.55 million AUD, but there is no indication of growth or decline compared to previous periods. The company faces a medium liquidity risk, as indicated by the risk assessment, and the financial snapshot shows that the company has a negative net cash position after subtracting total debt. The dilution risk is assessed as low, and there are no adjustments applied in the custom valuations that would suggest a significant change in the company's capital structure. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial position. The company's financial performance and risk profile are based on the latest available financial data.

30-day price · CQT(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCONNEQT Health Ltd
TickerCQT.AX
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Conneqt Health Limited develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health, specializing in the SphygmoCor vascular biosensing technology to measure arterial health and provide clinical-grade arterial assessment.

Classification. Conneqt Health is classified in the Healthcare sector under the Advanced Medical Equipment & Technology industry with a confidence level of 0.92.

Conneqt Health has a liquidity risk with a debt-to-equity ratio of 5.79 and a current ratio of 0.9, indicating that the company's liabilities significantly outweigh its equity and that it may struggle to meet short-term obligations. The company's free cash flow is negative at -17.9 million AUD, and its operating cash flow is also negative at -10.9 million AUD, suggesting that the company is not generating sufficient cash from operations to sustain its activities. In terms of profitability, Conneqt Health is not performing well, with a return on equity of -28.72% and a return on assets of -1.95%. These figures are significantly below the industry norms for a company in the Advanced Medical Equipment & Technology industry, indicating that the company is not effectively utilizing its assets or equity to generate returns. The company's revenue is concentrated in a single business segment, as it operates in the digital health technology space with a focus on cardiovascular health monitoring. There is no disclosed geographic diversification in the financial snapshot, suggesting that the company's revenue is primarily derived from its operations in Australia. Conneqt Health's growth trajectory is not evident from the provided data, as the company reported a net loss of 18.2 million AUD and an operating loss of 12.8 million AUD. The company's revenue for the latest period is 3.55 million AUD, but there is no indication of growth or decline compared to previous periods. The company faces a medium liquidity risk, as indicated by the risk assessment, and the financial snapshot shows that the company has a negative net cash position after subtracting total debt. The dilution risk is assessed as low, and there are no adjustments applied in the custom valuations that would suggest a significant change in the company's capital structure. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial position. The company's financial performance and risk profile are based on the latest available financial data.
Key takeaways
  • Conneqt Health has a high debt-to-equity ratio and a low current ratio, indicating significant liquidity risk.
  • The company is not profitable, with a negative return on equity and return on assets.
  • Revenue is concentrated in a single business segment with no disclosed geographic diversification.
  • The company's growth trajectory is unclear, with no indication of revenue growth or decline.
  • The company has a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's margin outlook is negative due to its high operating and net losses.",
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$3.6M
Gross profit$2.6M
Operating income-$12.8M
Net income-$18.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$10.9M
CapEx-$26.3k
Free cash flow-$17.9M
Total assets$9.3M
Total liabilities$8.7M
Total equity$633.5k
Cash & equivalents
Long-term debt$3.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$633.5k
Net cash-$3.7M
Current ratio0.9
Debt/Equity5.8
ROA-2.0%
ROE-28.7%
Cash conversion60.0%
CapEx/Revenue-0.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Advanced Medical Equipment & Technology · cohort 3 companies
MetricCQTActivity
Op margin-360.0%19.4% medp25 17.8% · p75 22.0%bottom quartile
Net margin-511.9%17.7% medp25 16.4% · p75 19.0%bottom quartile
Gross margin72.0%73.5% medp25 71.3% · p75 75.8%below median
R&D / revenue6.2% medp25 4.7% · p75 12.0%
CapEx / revenue-0.7%4.3% medp25 3.9% · p75 4.3%bottom quartile
Debt / equity579.0%41.5% medp25 29.2% · p75 51.3%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:22 UTC#389c5476
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:23 UTCJob: 7252231e